Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
201.8 USD | -3.28% | -9.27% | -19.76% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.76% | 8.08B | |
+71.87% | 12.28B | |
+15.96% | 7.23B | |
-6.42% | 5.29B | |
+4.54% | 4.93B | |
+18.62% | 4.19B | |
-21.30% | 4.13B | |
-40.48% | 2.24B | |
-3.47% | 2B | |
-4.68% | 1.7B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Earnings Flash (PEN) PENUMBRA Posts Q1 Revenue $203.9M, vs. Street Est of $195.4M